Phase I/II Study of Z-208 in Advanced Hepatocellular Carcinoma (HCC)

Clinical trial NCT00731445 · COMPLETED

Trial details

NCT number: NCT00731445
Sponsor: Zeria Pharmaceutical
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Hepatocellular Carcinoma

Start date: 2008-07-01
Primary completion: 2012-01-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.